InVivo Therapeutics Announces Full Exercise of Over-Allotment Option

(otc/bb:NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries, today announced the full exercise of the over-allotment option granted to the underwriters to purchase 1242236 additional shares, at a public offering …
See all stories on this topic »